NCT03598699View on ClinicalTrials.gov

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

December 28, 2018

Study Completion Date

January 9, 2019

Conditions

Dry Eye

Interventions

DRUG

AXR-159

AXR-159 Ophthalmic Solution

DRUG

Vehicle

AXR-159 Ophthalmic Solution Vehicle

Trial Locations (3)

38119

Total Eye Care, P.A., Memphis

01810

Andover Eye Associates, Andover

02767

Andover Eye Associates, Raynham

Sponsors

Lead Sponsor

AxeroVision, Inc.

All Listed Sponsors

collaborator

ORA, Inc.

INDUSTRY

lead

AxeroVision, Inc.

INDUSTRY

NCT03598699 - A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease | Biotech Hunter | Biotech Hunter